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Abstract
Background: A variety of N-glycans attached to protein are known to involve in many important biological functions.
Endoplasmic reticulum (ER) and Golgi localized enzymes are responsible to this template-independent glycan synthesis
resulting glycoforms at each asparagine residues. The regulation mechanism such glycan synthesis remains largely
unknown.
Methodology/Principal Findings: In order to investigate the relationship between glycan structure and protein
conformation, we analyzed a glycoprotein of Drosophila melanogaster, chaoptin (Chp), which is localized in photoreceptor
cells and is bound to the cell membrane via a glycosylphosphatidylinositol anchor. Detailed analysis based on mass
spectrometry revealed the presence of 13 N-glycosylation sites and the composition of the glycoform at each site. The
synthetic pathway of glycans was speculated from the observed glycan structures and the composition at each N-
glycosylation site, where the presence of novel routes were suggested. The distribution of glycoforms on a Chp polypeptide
suggested that various processing enzymes act on the exterior of Chp in the Golgi apparatus, although virtually no enzyme
can gain access to the interior of the horseshoe-shaped scaffold, hence explaining the presence of longer glycans within the
interior. Furthermore, analysis of Chp from a mutant (RNAi against dolichyl-phosphate a-D-mannosyltransferase), which
affects N-glycan synthesis in the ER, revealed that truncated glycan structures were processed. As a result, the distribution of
glycoforms was affected for the high-mannose-type glycans only, whereas other types of glycans remained similar to those
observed in the control and wild-type.
Conclusions/Significance: These results indicate that glycan processing depends largely on the backbone structure of the
parent polypeptide. The information we obtained can be applied to other members of the LRR family of proteins.
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Introduction
Many proteins exposed on the surface of cells are modified with
various types of oligosaccharide. For example, N-linked oligosac-
charides are attached to the asparagine residues in the consensus
sequence NXS/T, where X can be any amino acid other than
proline. It is known that a variety of oligosaccharides are present at
certain asparagine residues giving rise to different glycoforms; this
consequently makes the structural and biological investigation
of these molecules more difficult. In some cases, the NXS/T
sequences at different sites of a single polypeptide are modified
with different types of N-linked oligosaccharide, such as high-
mannose, complex, and hybrid types, in a site-specific manner.
However, it remains largely unknown how this site-specific
modification is regulated within the Golgi apparatus.
In order to investigate these processes, we selected chaoptin
(Chp), a large Drosophila glycoprotein containing 16 potential
N-linked glycosylation sites, as a model protein [1]. Chp is
required for the development and maintenance of photoreceptor
cells, probably through its adhesive activity [2–4]. It is anchored to
the extracellular surface of the plasma membrane via covalent
attachment to a glycosylphosphatidylinositol (GPI) anchor [5]. On
the basis of the available genetic information (Swiss-Prot/
TrFMBL database: P12024), the deduced molecular mass for
the 1,286 amino acids of Chp is 148,550 Da. Chp is a member of
the leucine-rich repeat (LRR) (an average length of 24 amino
acids) family of proteins and consists of 38 LRRs that constitute
approximately 90% of the entire polypeptide. Proteins belonging
to the LRR family are found in yeast, Drosophila, and humans
[1,6,7], and generally fold into a non-globular horseshoe shape.
Eleven-residue segments, LxxLxLxxN/CxL (where X can be any
amino acid and L can also be replaced by V, I, or F),
corresponding to the b-strand and adjacent loop regions are
conserved in Chp and other LRR proteins [8,9]. Thus, Chp is
PLoS ONE | www.plosone.org 1 May 2009 | Volume 4 | Issue 5 | e5434thought to have a folded configuration similar to that of other
reported LRR family members [1,10].
The potential N-glycosylation sites are readily identified within
the Chp consensus sequence. The heavy glycosylation of Chp has
been demonstrated by glycosidase treatment that dramatically
reduced the apparent molecular mass of Chp (160 kDa), as
estimated by sodium dodecyl sulfate-polyacrylamide gel electro-
phoresis. The involvement of N-glycans in intercellular recogni-
tion and formation of the eye structure has previously been
suggested; however, the role of individual N-glycans at each site is
not known [11]. Therefore, it is essential to reveal the structure of
glycans at individual glycosylation sites, since the glycan at a
particular site or a specific glycan structure might have a crucial
function [12–16].
Despite interest in the nature of adhesion capabilities, the
elucidation of glycan structure, the glycoforms, and the position of
glycan attachment remains a challenging task [17]. Mass
spectrometry (MS)-based methods are considered to be advanta-
geous in this respect, owing to their high sensitivity and lower
sample consumption [18–21]. In order to clarify the role of glycan
structure in glycoproteins in general, a methodology capable of
elucidating the structure of glycoproteins of a relatively large size
(greater than 100 kDa) is essential. To this end, we decided to
analyze the structure of Chp in order to resolve its glycan
components. It is envisaged that the information thus obtained will
be useful in functional investigations based on mass spectrometry.
Here, for the first time, we describe a detailed glycoform at each
N-glycosylation site of Chp, an attainment achieved using a
technique based on matrix-assisted laser desorption ionization
time-of-flight mass spectrometry (MALDI-TOF-MS). The results
revealed that high-mannose-type glycans do not co-exist with
shorter glycans consisting of extra N-acetylgulcosamine (GlcNAc)
and/or fucose (Fuc) residues at the same site, thereby giving rise to
different glycoforms, and suggesting the existence of a secondary
structure-dependent regulatory mechanism for glycan synthesis.
To the best of our knowledge, this is the first demonstration of a
relationship between protein structure and glycan processing.
Having performed the Chp analysis, a knockdown experiment
based on RNA interference (RNAi) against dolichyl-phosphate a-
D-mannosyltransferase (Dol-P-ManTase), defects of which are
related to carbohydrate-deficient glycoprotein syndrome (CDGS)
type IV [22], was carried out. The knockdown experiment failed
to yield any detectable eye phenotypes, suggesting that either a
‘‘sufficient amount’’ of wild-type equivalent Chp was synthesized
and correctly expressed or that the affected part of the glycans was
not essential for adhesion. However, the glycan analysis revealed
similar glycan abundance at individual sites, except for the
truncated glycan structure in the high-mannose-type glycoform,
suggesting that glycan processing in the Golgi apparatus is
restricted by protein conformation.
Results
Analysis Flow of Chp Glycoforms
The protocol followed in the current investigation is summa-
rized in Figure 1. Briefly, Chp obtained by affinity chromatogra-
phy using an anti-Chp antibody (MAb24B10) was digested by
trypsin, dephosphorylated, and then guanidinated. The mixture
thus obtained, which contained both peptides and glycopeptides,
was passed through a cellulose cartridge column in order to enrich
the glycopeptides [23]. The enriched glycopeptide fractions were
used in the subsequent analyses. A portion of the crude
glycopeptide was further treated with PNGase F to determine
the sites of N-linked glycan attachment. This step, which involves
the conversion of a glycosylated asparagine residue to aspartate,
was necessary for a rapid assessment of glycan presence and
location.
Figure 1. Flow chart of the sequence analysis of a glycoprotein.
The purified glycoprotein is denatured and alkylated prior to tryptic
digestion. The digests are subsequently subjected to guanidination in
order to overcome the problem of ion suppression caused by peptides
lacking arginines. Following the enrichment of glycopeptides using a
cellulose cartridge column, the guanidinated tryptic digests were
divided into 2 portions. One portion was subjected to PNGase F
treatment followed by reverse-phase cartridge purification to deter-
mine the sites of N-glycosylation. The fraction containing multiple
potential N-glycosylation sites was further treated with endoproteinase
AspN. The other portion was fractionated by reverse-phase HPLC
followed by MS and MS/MS analysis to obtain the glycan sequence.
doi:10.1371/journal.pone.0005434.g001
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glycoprotein with multiple glycosylation sites is complicated.
Furthermore, the direct analysis of tryptic digests of glycoproteins
is often unproductive since the presence of heterogeneity (glyco-
forms) at each glycosylation site means that only small amounts of
individual glycopeptides are present. The analytical difficulty is
compounded by the problem of ion suppression that arises from
the presence of non-glycosylated peptides in a fraction. Hence, in
the present investigation, the major portion of the glycopeptide
mixture was further purified by HPLC and individual fractions
were analyzed by MS. We decided to use the combination of a
TOF mass analyzer, which is advantageous for detecting relatively
large ion species, and MALDI as the ionization method, since this
permits the ionization of trace amounts.
Determination of N-Glycosylation Sites
The tryptic peptide sequences containing potential N-glycosyl-
ation sites are listed in Table 1. Twelve out of 16 potential N-
linked glycosylation sites with expected m/z values were detected
from MS analysis of the peptide fractions obtained by PNGase F
treatment of enriched glycopeptides (Figure 1). From a comparison
of the expected m/z values calculated for a peptide with known
sequences and the observed values, we were able to determine the
sites of N-glycan attachment within a margin of error.
Peptide modifications are often observed in mass spectra and
provide useful information for the annotation of amino acid
sequences. Methionines in tryptic peptides (see Nos. 1, 6, 7, 11,
and 14 in Table 1) were oxidized, and thus ions such as
[M(Met)+1(H)+16(O)]
+ and [M(Met)+1(H)+16(O)264(CH3-
SOH)]
+ were observed as well as a protonated molecule,
[M(Met)+1(H)]
+. Further, glutamine at the N terminus (see
No. 7 in Table 1) was partially observed as a pyroglutamate
[Q(Gln)+1(H)217(NH3)]
+ [24] (Figure S1). A sequence for the
peptide I
711–R
728 (No. 9) was obtained even though there was no
report that trypsin cleaves the linkage between arginine and
proline for a sequence of …FRP…
Among the peptides that were confirmed to be N-glycosylated,
peptide Y
334–K
364 (No. 4) had 2 potential N-glycosylation sites
(N
339 and N
361). It appeared from the MS analysis of N-
glycosylation sites that an increase in m/z value by only 1 amu
could not be reliably made for the analysis of ions over m/z 3000.
As an alternative, we decided to treat the peptides obtained by
PNGase F treatment with AspN endoproteinase. AspN cleaves the
N terminus of aspartate (D), and therefore should produce a new
peptide terminating with D instead of N. As a result, the peptide
YCGLTN
339ISPVAFDSLVNSLQILDLSGNN
361LTK yielded
D
361LTK and YCGLTN
339ISPVAF in which only N
361 was
converted to D, indicating that this particular position in the
peptide was N-glycosylated (Figure S2).
With regard to positions N
422 and N
1171, it was not possible to
ascertain the presence or absence of a glycan since glycanase is
unable to hydrolyze glycans when the N-terminal asparagine is
glycosylated [25]. Therefore, we performed MS/MS analysis of
the RP-HPLC fractions (Figure 1) in order to confirm the presence
Table 1. Masses of Tryptic Peptides from Chaoptin Following PNGase F Treatment.
Peptide
number Tryptic fragment
Sequence containing
N-glycosylation site
Average
mass of M+H+ Detected
M+H
+ (m/z)
M+16+H
+
(m/z)
a
M-48+H
+
(m/z)
b
M-17+H
+
(m/z)
c
1 75–80 MVD
77QSK
g 749.83 750.4 766.4 702.7
2 253–273 TLDISHNVIWSLSGD
267ETYEIK
g 2463.68 2462.7
3 300–306 YFDTVD
305R 915.97 916.6
4 334–364 YC*GLTN
339ISPVAFDSLVNSLQILDLSGND
361LTK
g 3411.83 3410.9
5 422–425 N
422MTR 521.61 n.d.
6 650–687 LEILDMAFNQLPNFNFDYFDQVGTLSNLNVD
680VSHNQIR 4443.93 4442.2 4457.8 4394.6
7 688–698 QLMYD
692SSWSGR 1330.45 1330.2 1346.5 1283.2 1313.7
8 711–749 ILDLSHND
718ISIIHPGYFRPA EISLTHLHLGYNSLMD
746TTR 4463.06 n.d.
9
$ 711–728 ILDLSHND
718ISIIHPGYFR
d 2111.40 2111.2
10 932–946 LGLED
936V
#SLSTVPEIR 1628.86 1627.9
11 955–975 LGYNELPSIPQELAHD
970MSNLR 2398.69 2397.6 2412.4 2349.3
12 1000–1031 LMLSGNPITSLND
1012NSFDGVNEDLEMLDISNFR 3572.93 3571.8 3587.4 3524.4
13 1120–1136 LTD
1122ITFSGPQFTNLNER 1954.14 1955.0
14 1143–1164 SPYLYMQLFD
1152TSLQALPPNFFK
g 2664.07 2662.6 2678.4 2616.1
15 1171–1177 N
1171ISLDIR 830.47 n.d.
aThe observed m/z value for the oxidized Met [M(Met)+1(H)+16(O)]
+.
bThe observed m/z value for the [M(Met)+1(H)+16(O)-64(CH3SOH)]
+.
cThe observed m/z value for the pyroglutamate [Q(Gln)+1(H)-17(NH3)]
+.
dA peptide corresponding to a sequence P
729–R
749 was not observed because it was removed by the purification step using the cellulose cartridge column.
D: N-glycosylation site determined by PNGase F treatment.
C*: carbamidomethyl cysteine.
K
g: guanidinated lysine.
V
#: undetermined.
Underline: non-glycosylated N.
n.d.: not detected.
The sequence of 9
$ is a fragment of 8.
doi:10.1371/journal.pone.0005434.t001
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that was not initially identified as being glycosylated was
additionally established to be a site carrying an N-glycan based
on MS/MS analysis of the glycopeptide fraction. Thus, a total of
13 N-glycosylation sites were confirmed among the 16 potential
sites.
Glycoform Analysis at Each Glycosylation Site
Following separation by reverse-phase (RP) HPLC, the
glycopeptide fractions were analyzed by MALDI-TOF-MS and
MS/MS. The fractions containing glycopeptides were identified in
a chromatogram by the presence of a series of signals due to the
glycoform. The retention of glycopeptides depends on the
hydrophobicity associated with hydrophobic residues in peptides;
thus, a series of glycopeptides sharing the same peptide sequence
results in a series of peaks. Following MS, the glycopeptide peaks
were shown to differ by m/z 203 (GlcNAc, Gn), 162 [mannose
(Man), M or glucose (Glc), G], or 146 (Fuc, F). We assessed glycan
composition on the basis of the m/z values only because it is
practically impossible to determine the linkage position and
anomeric configuration based on the current setup of the MS
experiment without methylation that provides information regard-
ing linkage position. Examples of the mass spectra of glycopeptides
with different glycoforms are shown in Figure 2A and 2B. Analysis
of the glycopeptides containing N
970 revealed the presence of 4
glycans that were of the pauci-mannose type (Figure 2A). The
glycoform found at N
1122 consisted of high-mannose-type glycans
containing 5 to 11 hexoses (Figure 2B). We were concerned that
immature glycoproteins being synthesized in the endoplasmic
reticulum (ER) and Golgi might be analyzed together with mature
forms. However, immunostaining of photoreceptor cells using
anti-Chp antibody (24B10) revealed that the Chp was accumulat-
ed in the rhabdomeres, indicating that the majority of the glyco-
proteins we analyzed were of the mature form (Figure 2D–2F).
Drosophila N-glycans are classified into 3 types; namely, high-
mannose, pauci-mannose, and complex types. The relationship
between observed glycan structure and the site of attachment is
shown in Figure 2C, where the numbers along the horizontal axis
indicate the position of the observed N-glycosylated asparagine in
the polypeptide sequence, and the color indicates observed glycan
structures. High-mannose-type glycans were observed at 10
positions (N
77,N
305,N
361,N
680,N
692,N
718,N
936,N
1122,N
1152,
and N
1171). In contrast, complex-type glycans were observed at 2
positions (N
267 and N
1012), whereas pauci-mannose-type glycans
were observed at 5 positions (N
77,N
267,N
305,N
692, and N
970).
The glycans at positions N
77 and N
305 contained relatively short
high-mannose-type and pauci-mannose-type glycans consisting of
only Man residues other than chitobiose, whereas the glycans at
position N
692 contained a Fuc residue. The distribution of
glycoforms at each site appears to be controlled since high-
mannose-type glycans and shorter glycans that contain extra
GlcNAc and/or Fuc residues (pauci-mannose and complex types)
do not co-exist at the same site, thereby giving rise to different
glycoforms. On the basis of these observations, it would appear
that the state of the glycoform is, to a certain extent, dependent
upon its position within the peptide.
The glycan structures expected from the observed glycan
compositions are summarized in the predicted synthetic pathway
depicted in Figure 3. This confirmed the presence of most of the
reported glycan structures, although some of the important
intermediates are absent. The structures indicated in parentheses
in route a (M5Gn2RM5Gn3RM4Gn3RM3Gn3) and route b
(M3Gn3RM3Gn4RM3FGn4), which are the accepted synthetic
pathways, denote undetected glycans; these structures could exist
as intermediates, although they may be present in undetectable
amounts (see Discussion).
Glycan structures can be categorized by the processing enzymes
involved in their synthesis. GM9Gn2 (Figure S3A), which is
processed by a-glucosidase I and II (Glcase I and II) following
attachment of the oligosaccharide G3M9Gn2 to a polypeptide in
the ER, but not completely processed by Glcase II in the ER, was
found at positions N
680,N
936,N
1122, and N
1171. Glycan structures
formed by the a-mannosidase I (Manase I) reaction in the Golgi
apparatus, subsequent to the reactions of Glcase I and II in the
ER, were observed at positions N
361 and N
1152. High-mannose-
type glycans were also observed at positions N
77,N
305, and N
718.
The glycans at N
77 and N
305 were of a pauci-mannose type,
although the glycan at N
718 was of a high-mannose type only.
These glycans are thought to be the products formed by the
reactions of Manase without any subsequent reactions mediated
by N-acetylglucosaminyltransferase I (GnTase I) and fucosyltrans-
ferase (FucTase).
In contrast, the products of the sequential reactions of both
GnTase I and FucTase(s), which are classified as the complex type,
were observed at positions N
267 and N
1012. These glycans
contained both a-(1R3)- and a-(1R6)-linked Fuc residues. It has
been reported that a-(1R3)-linked Fuc is abundant in the neural
system [26], an observation that has been confirmed by using anti-
HRP antibody [27]. Although we confirmed the presence of the a-
(1R3)-linked Fuc, immunostaining experiments using anti-HRP
antibody indicated that the residue was not abundant in Chp [28].
In Drosophila, Fuc can be attached to the core GlcNAc by a-(1R3)
and/or (1R6) linkages [29]. Thus, the linkage position of mono-
fucosylated glycans, which are of the pauci-mannose type, in the
glycoforms at N
267,N
692,N
970, and N
1012 could not be
determined by MS (Figure S3B). The knockdown mutant analysis
of a-(1R3) FucTase or a-(1R6) FucTase, or more practically
PNGase A treatment [30], could provide more detail information,
although we may be able to determine glycan structure by
referring to the synthetic pathway [31–33].
Relationship between Protein Conformation and Glycan
Structure
In Figure 4, we present a schematic representation of Chp in
order to illustrate the relationship between glycan structure and
protein conformation based on the characteristic folding of the
LRR motif. Figure 4A shows the secondary structure of Chp
predicted by PSIPRED ver. 2.6 (http://bioinf.cs.ucl.ac.uk/
psipred/psiform.html) in which the glycan attachment sites and
glycoform contents are indicated. The polypeptide structure of
Chp is thought to be constructed of a b-strand and a-helix or to be
alternately coiled owing to the LRR motifs (Figure 4B). Although
the crystal structure of Chp is not currently available, the
conformation might be similar to that of other LRR family
proteins, e.g., the Toll-like receptor [34]. Furthermore, this
conformation was confirmed by the observation of arch-shaped
Chp molecules by atomic force microscopy (Figure 4C). The fact
that the individual molecules observed had an arch shape suggests
that the Chp folded correctly overall. This was also supported by
the localization of the glycoprotein in the rhabdomeres.
In Figure 4A, the content of color-coordinated glycan structures
are indicated as percentages estimated from the height of the
signals in the mass spectra for individual sites (also see Figure 2C).
This representation was made possible based on the fact that the
ionization tendency of glycopeptides depends mostly on the
peptide portion; thus, quasi-quantitative data analysis of a
glycopeptide can be performed [35,36]. The spectrum shown in
Figure 4A clearly indicates that high-mannose-, pauci-mannose-,
Glycoform of Chaptin
PLoS ONE | www.plosone.org 4 May 2009 | Volume 4 | Issue 5 | e5434Figure 2. Mass spectra and structural variation of the N-glycans of chaoptin. (A) Mass spectrum of a glycopeptide fraction containing
pauci-mannose-type glycans following RP-HPLC. The structures of the 4 glycans observed at N
970 are shown schematically. The glycopeptide signals
are spaced by 162 amu (mannose, M) or 146 amu (fucose, F). (B) Mass spectrum of a glycoprotein fraction that contains high-mannose-type glycans in
which 7 glycans are observed at N
1122. The signals spaced by 162 amu correspond to a number of mannose (M) or glucose (G) residues. (C) Observed
glycan structures at each glycosylation site are shown. The horizontal and longitudinal axes show the position of asparagine (Asn) in the polypeptide
and glycan structures, respectively. Distinctive colors are assigned to the individual glycan structures, which are used in the paper hereafter. (D) The
majority of Chp is localized in the rhabdomeres as determined by staining with anti-Chp antibody and Alexa Fluor 488-conjugated anti-mouse IgM.
TMR (tetramethylrhodamine)-phalloidin staining against F-actin. (E) A longitudinal conforcal image: same staining as in D. (F) Photorecepter cells were
stained (longitudinal image) using TMR-phalloidin and anti-KDEL antibody and Alexa-Fluor-488 conjugated anti-mouse IgG.
doi:10.1371/journal.pone.0005434.g002
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within the Chp polypeptide.
With the exception of N
77, which is not located in the LRR, the
N-glycosylation sites attached with high-mannose-type glycans are
located in the b-strand region in the interior of the arch. At other
N-glycosylation sites located outside of the b-strand, the glycans at
positions N
267 and N
1012 were found to be of a complex type.
Moreover, the glycans at positions N
692 and N
970 were found to be
of a pauci-mannose-type. These glycans are thought to be located
in either the loop or the a-helix at the exterior of the arch-shaped
Chp. These results revealed that complex- and pauci-mannose-
type glycans are located on the more exposed surface of the
protein.
Glycan Analysis of Chp from a Knockdown Mutant
The results of the glycoform analysis described above reveal not
only the structures of the glycans but also information on the
enzymes involved in their synthesis. Consequently, an analysis of
the relevant mutants could provide important insights into the
regulation of glycan synthesis. In order to confirm the quasi-
quantitative analysis of a glycoform based on the MS of mutants
and to obtain control values for analysis of the subsequent
knockdown experiments prior to interference, we initially
performed an analysis of organisms carrying green fluorescent
protein-inverted repeat (GFP-IR) as a control [37].
In addition, we analyzed Chp from an organism in which the
gene (CG10166) encoding the enzyme Dol-P-ManTase [2.4.1.83]
had been knocked down (Figure 5). Deficiency in this gene is
known to cause CDGS type IV in human. Patients with this
condition are characterized by the production of a truncated lipid-
linked oligosaccharide containing only 5 Man residues, whereas
normal individuals produce an oligosaccharide containing 9 Man
residues (Figure 5A). Although this oligosaccharide is faithfully
transferred to a protein, subsequent oligosaccharide processing is
abnormal in the hybrid-type glycans [22]. Dol-P-ManTase
transfers a Man residue from GDP-Man to dolichyl-phosphate,
and the resulting product, dolichyl-phosphate a-D-mannose (Dol-
P-Man), is used as a substrate in the synthesis of M9Gn2PPDol
from M5Gn2PPDol (Figure 5A). Dol-P-Man is also used as a
substrate in the synthesis of the GPI anchor. Thus, the knockdown
of Dol-P-ManTase may disrupt the synthesis of both N-glycan and
the GPI anchor owing to the resulting shortage of Dol-P-Man.
Since Chp is a glycoprotein linked to a GPI anchor, the correct
expression of Chp at the plasma membrane may rely on the
Figure 3. Schematic representation of N-glycan processing in Drosophila. The N-glycan synthetic pathway in wild-type Drosophila is shown.
The scheme was created based on a previously reported synthetic pathway and the results presented in Figure 2C. An enzyme indicated as Manase X
has not been identified. Route a and route b are the predicted pathways, although intermediates, described in parentheses, within the 2 pathways
have not been observed.
doi:10.1371/journal.pone.0005434.g003
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PLoS ONE | www.plosone.org 7 May 2009 | Volume 4 | Issue 5 | e5434complete synthesis of the GPI anchor as well as the N-glycans. An
additional important objective in this context is to provide
evidence for the suggested regulation of glycan processing that
relates to the conformation of the Chp polypeptide. The
knockdown of Dol-P-ManTase would result in a shortage of
Dol-P-Man, and thus yield Chp with truncated glycans.
The differences in glycan structure can also be addressed
by considering processing on the interior and exterior of the
arched-shape Chp molecule. First, the overall profile of the
observed glycoform of the control and the wild-type closely
resembled each other showing good reproducibility where the MS-
based analysis could be performed in a quasi-quantitative manner
(Figure 5B). Analysis of Chp from the CG10166 mutant
revealed that it exhibited no obvious physical phenotypes.
Furthermore, detailed analysis of the mutant revealed that the
constitution of the rhabdomeres was not affected, as confirmed
Figure 5. M9Gn2PPDol synthesis and the relative abundance of N-glycan in wild-type, control, and mutant (CG10166) Drosophila. (A)
Dolichyl-phosphate a-D-mannosyltransferase (Dol-P-ManTase) [2.4.1.83], is converted to Dol-P-Man from GDP-Man, and serves as a donor substrate in
the synthesis of M9Gn2PPDol from the donor M5Gn2PPDol in N-glycan synthesis. (B) Contents of glycoforms at individual glycosylation sites are
indicated as percentages (colors are coordinated with those in Figure 2 and Figure 4). Due to the detection limit of mass spectrometry, the
glycopeptide signals at position N
267 in the mutant did not provide sufficient intensities to enable an estimation of glycoform abundance; thus, the
data are not shown. Observed glycans are M3, M3F, GnM3F, and Gn2M3F.
doi:10.1371/journal.pone.0005434.g005
Figure 4. Predicted secondary structure of chp with details of the glycoforms at each glycosylation site. (A) Protein secondary structure
was predicted by PSIPRED ver. 2.6. N-glycosylation sites are indicated by red dots and the contents of individual glycoforms are shown (color
coordinated with those in Figure 2). (B) A slice section of LLR (AA
648–AA
729) with b-strands located on the inner side and a-helices or coils located on
the outer side. The positions of N-glycosylation sites, N
680 carrying high-mannose-type glycans only, and N
692 carrying shorter glycans are shown as
space-filled representations. The model was generated using Swiss-PdbViewer ver. OSX 3.9b2. (C) Atomic force microscopy image of Chp (wild-type
with glycans attached) showing the overall horseshoe-shaped structure. The image shows possibly 8 individual Chp molecules. Each object
represents a single Chp molecule carrying one of the glycoforms. Most of the molecules have similar arch-shaped structures with some variations.
This might reflect an inherent feature of the glycoform but is considered more likely to be due to the resolution of the method used.
doi:10.1371/journal.pone.0005434.g004
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an accumulation of Chp in the ER was not evident from these
experiments (Data not shown). Thus, it was considered that a
sufficient amount of Dol-P-Man was synthesized under the RNAi
conditions. On the basis of the glycoform analysis of Chp in the
CG10166 mutant, it was determined that the structure of only the
high-mannose-type glycans was affected, whereas the distribution
of pauci-mannose- and complex-type glycans remained similar to
those observed in the control and wild-type. It is conceivable that
M5Gn2PPDol was transferred to Chp polypeptide instead of
M9Gn2PPDol in patients with CDGS type IV. Furthermore, the
shorter glycans transferred to the outer surface of Chp were
correctly processed, which suggests that the oligosaccharyltrans-
ferase, Glcases, Manase I, and possibly GnTase I do not require
the missing branch structure for substrate recognition. In spite of
these features, glycans containing shorter chains attached to the b-
strands were not further processed, which strongly suggests the
involvement of steric factors in the regulation of glycan processing.
Since a portion of the transferred glycan structures was shorter
than normal in circumstances where glycan processing was
affected by the RNAi, we performed a further structural analysis
of these glycans. The HPLC fractions of glycopeptides containing
M9Gn2 or GM9Gn2 were treated with PNGase F in order to
release glycans; these glycans were then pyridylaminated and
separated by RP-HPLC (Figure 6A). The fractions thus obtained
were analyzed by MS. This analysis revealed the presence of the
glycans M5Gn2 and GM5Gn2 that lack an entire branch on a-
Man-(1R6)-b-Man in fractions (i) and (ii), respectively (Figure 6B).
Discussion
Most secreted and membrane-anchored proteins are posttrans-
lationally modified. One of the major types of protein modification
is glycosylation; however, the regulation of this process is not fully
understood. The difficulty in characterizing this process lies in its
template-independent nature in the Golgi apparatus. The
investigation of this mechanism is of importance since it is well
known that changes in the structures of glycans attached to a
protein occur depending on the status of a cell and that such
changes are also related to certain diseases [22]. We investigated
the relationship between glycan structure and backbone protein
folding using Chp, a glycoprotein found in Drosophila photorecep-
tor cells, which has 16 potential N-glycan attachment sites. The
protein is a member of the LRR family of proteins and is thus
thought to fold into an overall horseshoe-shaped structure. Our
detailed analysis of the site-specific N-glycan structures based on
MS confirmed the presence of 13 N-glycosylation sites, and, for
the first time, identified the individual glycoforms at each site.
These results highlight 2 important aspects of glycan processing:
(1) the nature of the synthetic pathways, since glycans are
synthesized by the sequential action of multiple enzymes; and (2)
the relationship between glycan structure and protein conforma-
tion based on the characteristic folding of LRR family proteins.
Although knowledge of the synthetic pathways of N-glycans in
Drosophila has been limited to the difference between hybrid-type
and pauci-mannose-type glycans [38], the synthetic pathways
could be predicted in detail based on the observed glycan
structures (Figure 3). We first focused on the synthetic pathway
of pauci-mannose-type glycans. It is conceivable that there are 2
routes to produce M3Gn3. Manase II is known to act on substrates
after the transfer of Gn onto M5Gn2 (route a) [39,40]; however,
intermediates such as M5Gn3 and M4Gn3 (shown in parentheses
in Figure 3) were not detected in our analysis. In contrast, M4Gn2
and M3Gn2, which lack certain Man residues without additional
Gn, were observed. This does not necessarily preclude the
presence of route a, but it does suggest the following 2 possibilities:
(1) the addition of a Gn residue may not be required for the Man
cleavage in Drosophila, and (2) the reaction rate of GnTase I might
be considerably faster than that of Manase II. A study of Manase
II-deficient mice suggested that an alternative enzyme with
overlapping activity might be responsible for the processes yielding
the observed structures (shown as Manase X in Figure 3) [41].
Drosophila might have other Manases, or one having a substrate
specificity different to that of mammalian Manase I. In this
respect, a glycoform analysis of a Manase mutant could provide
further information. Another interesting observation was that no
intermediates of the structure M3Gn4 (indicated with parentheses
in Figure 3) were found in the expected pathway (route b). This
also suggests the presence of an alternative route.
Furthermore, the existence of different types of glycans at
different positions in the Chp molecule makes it possible to discuss
the relationship between the regulation of glycan structure within
the protein conformation and the reactions of glycan-processing
enzymes. Among the different types of glycans, those mainly
containing M9Gn2 and GM9Gn2 were found in the b-strand
regions. We cannot exclude the possibility that the observed
G2M9Gn2 (N
1122) and GM9Gn2 (N
680,N
718,N
936,N
1122, and
N
1171) associate with immature glycoprotein in the ER (Figure 2C);
however, localization of Chp clearly revealed the accumulation of
Chp in the rhabdomeres (Figure 2D–2F). Taking the observed
intensities of GM9Gn2 (Figure 2B) into account, we believe that
the majority of glycoproteins we analyzed were mature. It is
suggested that the bulky glycans are located in the interior of the
Chp arch (Figure 4A–4C). On the other hand, it was found that
complex-type and pauci-mannose-type glycans were located on
the more exposed surface of the protein. Various processing
enzymes act on the exterior of Chp, although virtually no enzyme
can gain access to the interior of the horseshoe-shaped scaffold,
hence explaining the presence of longer glycans within the interior.
These observations were further corroborated by a knockdown
experiment. Mutant analysis revealed that truncated N-glycan
structures were processed in the same manner. The changes in N-
glycan structure occurring in the ER did not affect further
modification of the Chp glycans in the Golgi apparatus, and the
results strongly suggested the presence of a regulation of N-glycan
processing based on the 3-dimensional structure of the backbone
polypeptide [12,13].
Information regarding the quality control was also obtained
from mutant analysis. The protein sorting of Chp was normal
without any accumulation in the ER. This suggests that the
dolichyldiphosphooligosaccharide-protein oligosaccharyltransfer-
ase did not require modification (chain elongation) onto a-Man-
(1R6)-b-Man. Although it was shown that the oligosaccharyl-
transferase recognized the shorter glycan as a substrate, the
transfer efficiency might be affected. This was evident from the
HPLC analysis of glycopeptides released from the control and
mutant Chp, which revealed a decrease in the total amount of
glycopeptide in the mutant (Figure S4). This observation is well
supported by the observation of an increase in the incompletely
glycosylated transferrin in a patient with CDGS type IV [22].
In addition, the abovementioned structures were not important
for the quality control by Calnexin (CNX) and/or Calreticulin
(CRT) [42,43]. Indeed, it is also conceivable that Chp might not
require these controls for correct folding since the normal
distribution of Chp was observed in a cnx99A knockdown fly
[44]. It should be noted that, owing to the nature of the
knockdown experiments, normal glycans were also found;
however, the detection of glycans carrying Glc residue(s)
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PLoS ONE | www.plosone.org 9 May 2009 | Volume 4 | Issue 5 | e5434Figure 6. Mutant Glycan analysis based on HPLC and mass spectrometry. (A) RP-HPLC chromatograms of pyridylaminated (PA)-sugars,
which were prepared from mutant glycopeptides containing the following N-glycosylation sites: N
936 and N
1152 (a-1), and N
680, and N
1122 (a-2).
Chromatogram a-3 shows commercially available PA-sugars as a reference. A peak of unknown identity indicated by an asterisk that might be
associated with a reagent used for the fluorescent labeling appeared in all fractions. (B) Mass spectra of peak i (a-1) and peak ii (a-2) from the
chromatograms shown in (A). M9Gn2 and M5Gn2 were observed in the fraction containing peak i. GM9Gn2 and GM5Gn2 were observed in the
fraction containing peak ii.
doi:10.1371/journal.pone.0005434.g006
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680,N
936,N
1122, and
N
1171, indicates that modification of at least these locations was not
important for the quality control of Chp [45].
To conclude, our analysis of one of the major glycoproteins in
Drosophila photoreceptor cells, chaoptin (Chp), confirmed the
presence 13 N-glycosylation sites out of 16 potential sites. On the
basis of the MS and MS/MS analyses of proteolytic digests, it is
suggested that N-glycan processing in Chp depends largely on
protein folding. Various processing enzymes act on the exterior of
Chp, although virtually no enzyme can gain access to the interior
of the horseshoe-shaped scaffold, hence explaining the presence of
longer N-glycans within the interior. These observations were
further corroborated by a knockdown experiment. Although the
crystal structures of some LRR proteins have recently been
determined [34], no detailed information is currently available
regarding glycans since these are cleaved prior to crystallization.
The information we obtained can be applied to other members of
the LRR family of proteins. We also demonstrated, firstly, that
quasi-quantitative analysis was possible by performing analyses of
both wild-type and mutant Chp glycans, and, secondly, that
immature glycan structures lacking a-Man-(1R2)-a-Man-(1R3)
and a-Man-(1R2)-a-Man-(1R6) disaccharides, which under
normal circumstances should be attached to an a-Man-(1R6)-b-
Man branch, did not affect glycan maturation, and that the glycan
structure might not be important for the correct folding based on
CNX and/or CRT in Chp. On the basis of the observed glycan
structures, alternative glycan processing routes can be predicted
where these structures suggest the presence of a new route [41].
Finally, it should be noted that the MS-based technique described
herein could also be applied to the investigation of other
glycoproteins, since it is still quite difficult to perform analysis of
large glycoproteins with molecular masses exceeding 100,000 Da.
It is important to establish such a method as an analytical tool for
assessing any changes in glycan structures related to disease state,
differentiation, cell types, and glycoprotein as pharmaceutical.
Materials and Methods
Preparation of Chaoptin from Drosophila Heads
Heads of adult wild-type Canton-S Drosophila melanogaster were
homogenized in lysis buffer consisting of 10 mM sodium
phosphate (pH 7.0), 100 mM NaCl, 0.5% Triton X-100, and
complete protease inhibitor (Roche), using a Teflon homogenizer.
The lysate was centrifuged at 13,0006g for 10 min in order to
remove nuclei and debris. Clarification of the lysate was achieved
by passing it through a 0.22-mm PES filter (Millipore). Immu-
noaffinity purification of Chp was performed using columns of
protein G-Sepharose (GE Healthcare), to which anti-Chp
antibody (24B10) (University of Iowa DSHB) had been covalently
coupled [46–48]. The lysate was incubated with 24B10/protein
G-Sepharose for 2 h. The affinity column was subsequently
washed with the lysis buffer minus protease inhibitor, followed by
50 mM triethylamine-acetic acid (pH 4.5). Chp was eluted with
50 mM triethylamine-acetic acid (pH 3.5).
Mutant fly–RNAi fly lines were generated as described
previously [37]. Two transgenic fly stocks, GAL4-driver and
upstream activating sequence system-inverted repeat (UAS-IR),
were used in this system. The GAL4-driver fly has a transgene
containing the yeast transcriptional factor GAL4, the expression of
which is under the control of a cytoplasmic actin promoter. The
UAS-IR fly has a transgene containing the inverted repeat of
the target gene ligated to the UAS promoter, a target of GAL4.
In this investigation, GMR-GAL4 was used to eye-specifically
control RNA expression. In the F1 progeny of these flies, the
double-stranded RNA of the target gene is expressed ubiquitously
in all cells to induce the gene silencing.
Preparation of Glycopeptides
RapiGest (Waters) and dithiothreitol were added to 200 mlo fa
0.1 mg/mL protein solution (adjusted to pH 8.0 with 1 M
ammonium bicarbonate) to final concentrations of 0.1% (w/v)
and 5 mM, respectively. This mixture was then incubated for
30 min at 60uC. Iodoacetoamide was added to a final concentra-
tion of 15 mM, and reacted in the dark at room temperature for
30 min. Modified trypsin (Promega) was then added to a final
trypsin/glycoprotein ratio of 1/50 (w/w) and CaCl2 solution was
added to a final concentration of 1 mM. Tryptic digestion was
achieved by incubating overnight at 37uC. The digestion was
terminated by the addition of 1% trifluoroacetic acid (TFA). In
order to remove salt and trypsin, the tryptic digest was applied to a
Sep-Pak Light C18 cartridge column (Waters). The peptide
mixture was eluted using 60% acetonitrile containing 0.1% TFA
(4 mL) followed by washing with 0.1% TFA (10 mL). Dephos-
phorylation was achieved by incubating at 37uC overnight with
alkaline phosphatase (2.4 U; Toyobo) in 200 mLo f5 0 m M
ammonium bicarbonate (pH 8.0) containing 10 mM MgCl2.
The peptide mixture was guanidinated using a Guanidination kit
(SIGMA) following the manufacturer’s protocol [38,49]. The
reaction mixture was dried and dissolved in 500 mL of 500 mM
NH4OH. This resuspension was then mixed with 250 mLo f
500 mM O-methylisourea hemisulfate. Following incubation of
the mixture at 60uC for 30 min, 750 mL of 10% TFA was added.
A quarter of the reaction mixture was applied to a cellulose
cartridge column, and the peptide mixture was eluted with 3 mL
ethanol/75 mM ammonium bicarbonate (1:2) followed by wash-
ing with 10 mL n-butanol/ethanol/water/acetic acid
(4:1:0.97:0.03).
Peptide:N-glycanase F (PNGase F) Digestion of
Glycopeptides
A half volume of the cellulose cartridge eluent was dried and
dissolved in 50 mL of 20 mM phosphate buffer (pH 7.0). PNGase
F (0.5 U) was added to the peptide solution and digestion was
achieved by incubating at 37uC overnight. A portion of the
peptide mixture was desalted using a ZipTip m-C18 prior to MS
analysis.
HPLC Separation of Glycopeptides and Peptides
Glycopeptide and peptide mixtures were separated by RP-
HPLC using a 1.0-mm i.d.6100 mm, 5-mm Inertsil C18 column
(GL Science). All separations were performed using a mobile phase
of 0.1% TFA and 70% acetonitril containing 0.1% TFA with a
linear gradient mode at 35uC. The flow rate was set at 50 mL/min
and UV detection was performed at 215 nm.
Endoproteinase Asp-N Digestion of Peptides
HPLC peptide fractions were dried and dissolved in 20 mLo f
20 mM phosphate buffer (pH 7.0). To each mixture, 0.5 units of
endoproteinase Asp-N were added. The digestion was carried out
at 37uC for 3 h. The mixture was desalted using a ZipTip m-C18
prior to MS analysis.
MS Analysis of Glycopeptides and Peptides
The matrix for peptide analysis by MALDI-TOF-MS consisted
of either 10 mg/mL cyano-4-hydroxycinnamic acid in 50%
acetonitril or 0.1% TFA or 10 mg/mL 2,5-dihydroxybenzoic
acid in 10% ethanol. MALDI-TOF-MS spectra were acquired
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City, CA). Mass spectra were acquired in the positive linear mode.
MS/MS measurements were performed using an Ultraflex TOF/
TOF mass spectrometer with the LIFT-MS/MS facility in the
positive mode. (Bruker Daltonics GmbH, Hamburg, Germany).
Phalloidin- and Immuno-histochemistry
Adult Canton-S Drosophila were anesthetized with CO2 and then
decapitated. Retinas were excised from the heads using a razor
blade and a tungsten needle, immersed in 4% paraformaldehyde
in PBS containing 0.1% Triton X-100, and then incubated on ice
for 1 h. After rinsing in 0.1% Triton X-100 in PBS, the specimens
were incubated in 0.1% Triton X-100 and 0.1% BSA in PBS
(PBSTB) for 30 min at room temperature. The specimens were
then incubated with anti-Chp antibody (24B10) in PBSTB for 2 h
at room temperature. Following a rinse in PBSTB, the specimens
were incubated with rhodamine phalloidin (1:20; Invitrogen) in
PBSTB for 2 h at room temperature. The secondary antibody
used was Alexa Fluor 488-conjugated anti-mouse IgG (1:200;
Invitrogen). After rinses in PBSTB, the specimens were mounted
with Vectashield (Vector Laboratories, Burlingame, CA, USA)
and observed using a FluoView FV500 Laser Scanning Confocal
Microscope (Olympus, Tokyo, Japan).
Atomic Force Microscopy (AFM)
Freshly cleaved mica surfaces (20620 mm; Ted Pella, Redding,
CA, USA) were incubated with 20 mL 0.01% aminopropyl-
triethoxysilane (Gelest Inc.) water solution at room temperature
for 10 min, which was subsequently aspirated off. A 5-mL drop of
cosmid DNA 380H5 (0.1 mg/mL) bearing elongation complexes
was then spread on a mica surface by covering it with a clean glass
coverslip. The coverslip was peeled off after 5 min, and the mica
surface air-dried before imaging. Using a BioScope system with a
NanoScope IIIa controller (Digital Instruments, Santa Barbara,
CA, USA), tapping mode scans on mica in air were performed
with Metrology Probe Tap 300 tips (Ted Pella).
Pyridylamination of Glycans
HPLC fractions of glycopeptides were treated with PNGase F
and then dried. The reaction reagent was pyridylaminated using a
Pyridylamination Reagent kit (Takara Bio, Japan) according to the
manufacturer’s protocol [50,51]. The solutions for reduc-
tive amination were prepared as follows. 2-Aminopyridine
(300 mg) was dissolved in 100 mL of acetic acid at 80uC and
borane-dimethylamine complex (20 mg) was dissolved in 100 mL
of acetic acid. Reductive amination was performed by the addition
of 20 mL 2-aminopyridine solution to the treated fractions
followed by heating at 90uC for 1 h, and the subsequent addition
of 20 mL borane-dimethylamine complex solution with further
heating of the mixtures at 80uC for 1 h. Following concentration,
the mixtures were applied to a cellulose cartridge column.
Supporting Information
Figure S1 Mass spectra of tryptic peptides separated by Zip
Tipm-C18 with 10% (a), 30% (b), 50% (c), and 70% CH3CN (d)
after treatment with PNGase F of concentrated glycopeptides.
The numbers indicate the peptide numbers in Table 1, where a, b,
and c indicate the oxidized Met [M(Met)+1(H)+16(O)]
+,
[M(Met)+1(H)+16(O)-64(CH3SOH)]
+, and the pyroglutamate
[Q(Gln)+1(H)-17(NH3)]
+, respectively.
Found at: doi:10.1371/journal.pone.0005434.s001 (0.14 MB TIF)
Figure S2 Tandem mass spectrum of the signal (m/z 1341.5)
appeared after AspN treatment that was the peptide sequence
containing N
339 from a peptide Y
334–K
364 (No. 4 in Table 1).
Found at: doi:10.1371/journal.pone.0005434.s002 (0.10 MB TIF)
Figure S3 Tandem mass spectra of the glycopeptides of m/z
2858.0, which consisted of GlcM9Gn2 attached to N
1171ISLDIR
(a) and that of m/z 3703.2, which consisted of GnM3FGn2
attached to TLDISHNVIWSLSGN
267ETYEIK
g (b).
Found at: doi:10.1371/journal.pone.0005434.s003 (0.23 MB TIF)
Figure S4 RP-HPLC chromatogram of a glycopeptide-enriched
fraction of Chp from CG10166 knock down mutant (22 mg) (a) and
that from GFP-IR control (15 mg) (b). *: The peak containing
glycopeptides.
Found at: doi:10.1371/journal.pone.0005434.s004 (0.22 MB TIF)
Acknowledgments
We thank Dr. Hiroyuki Yano for measuring confocal image of
photoreceptor cells.
Author Contributions
Conceived and designed the experiments: YK SG OK. Performed the
experiments: YK MYH YK HY. Analyzed the data: YK HY. Contributed
reagents/materials/analysis tools: YK MYH SN RU SG. Wrote the paper:
YK OK.
References
1. Reinke R, Krantz DE, Yen D, Zipursky SL (1988) Chaoptin, a cell surface
glycoprotein required for Drosophila photoreceptor cell morphogenesis, contains a
repeat motif found in yeast and human. Cell 52: 291–301.
2. Krantz DE, Zipursky SL (1990) Drosophila chaoptin, a member of the leucine-
rich repeat family, is a photoreceptor cell-specific adhesion molecule. EMBO 9:
1969–1977.
3. Pollock JA, Ellisman MH, Benzer S (1990) Subcellular localization of transcripts
in Drosophila photoreceptor neurons: chaoptic mutants have an aberrant
distribution. Genes Dev 4: 806–821.
4. Zelhof AC, Hardy RW, Ann B, Zuker CS (2006) Transforming the architecture
of compound eyes. Nature 443: 696–699.
5. Van Vactor DJ, Krantz DE, Reinke R, Zipursky SL (1998) Analysis of mutants
in chaoptin, a photoreceptor cell-specific glycoprotein in Drosophila, reveals its
role in cellular morphogenesis. Cell 52: 281–290.
6. Yamawaki-Takaoka Y, Tamaoki T, Choe HR, Tanaka H, Takaoka T (1989)
Adenylate cyclases in yeast: A comparison of the genes from Schizosaccharomyces
pombe and Saccharomyces cerevisiae. Proc Natl Acad Sci USA 86: 5693–5697.
7. Krantz DD, Zidovetzki R, Kagan BL, Zipursky SL (1991) Amphipathic b
structure of a leucine-rich repeat peptide. J Biol Chem 266: 16801–16807.
8. Kajava AV, Vassart G, Wodak SJ (1995) Modeling of the three-dimensional
structure of proteins with the typical leucine-rich repeats. Structure 3: 867–877.
9. Kobe B, Kajava AV (2001) The leucine-rich repeat as a protein recognition
motif. Curr Opin Struct Biol 11: 725–732.
10. Gay NJ, Packman LC, Weldon MA, Barna JC (1991) A leucine-rich repeat
peptide derived from the Drosophila Toll receptor forms extended filaments with a
b-sheet structure. FEBS 291: 87–91.
11. Hirai-Fujita Y, Yamamoto-Hino M, Kanie O, Goto S (2008) N-Glycosylation of
Drosophila neural protein, chaoptin, is essential for its stability, cell surface
transport and adhesive activity. FEBS Lett 582: 2572–2576.
12. Cumming DA (1991) Glycosylation of recombinant protein therapeutics: control
and functional implications. Glycobiology 1: 115–130.
13. Lis H, Sharon N (1993) Protein glycosylation. Structural and functional aspects.
Eur J Biochem 218: 1–27.
14. Cointe D, Beliard R, Jorieux S, Leroy Y, Glacet A, et al. (2000) Unusual N-
glycosylation of a recombinant human erythropoietin expressed in a human
lymphoblastoid cell line does not alter its biological properties. Glycobiology 10:
511–519.
15. Branza-Nichita N, Negroiu G, Petrescu AJ, Garman EF, Platt FM, et al. (2000)
Mutations at critical N-glycosylation sites reduce tyrosinase activity by altering
folding and quality control. J Biol Chem 275: 8169–8175.
16. Walsh G, Jefferis R (2006) Post-translational modifications in the context of
therapeutic proteins. Nat Biotech 24: 1241–1252.
Glycoform of Chaptin
PLoS ONE | www.plosone.org 12 May 2009 | Volume 4 | Issue 5 | e543417. Wuher M, Catalina MI, Deelder AM, Hokke CH (2007) Glycoproteomics based
on tandem mass spectrometry of glycopeptides. J Chromatogr B 849: 115–128.
18. Dell A, Morris HR (2001) Glycoprotein structure determination by mass
spectrometry. Science 291: 2351–2356.
19. Wuher M, Hokke CH, Deelder AM (2004) Glycopeptide analysis by matrix-
assisted laser desorption/ionization tandem time-of-flight mass spectrometry
reveals novel features of horseradish peroxidase glycosylation. Rapid Commun
Mass Spectrom 18: 1741–1748.
20. Harazono A, Kawasaki N, Kawanishi T, Hayakawa T (2005) Site-specific
glycosylation analysis of human apolipoprotein B100 using LC/ESI MS/MS.
Glycobiology 15: 447–462.
21. Bykova NV, Rampitsch C, Krokhin O, Standing KG, Ens W (2006)
Determination and characterization of site-specific N-glycosylation using
MALDI-Qq-TOF tandem mass spectrometry: case study with a plant protease.
Anal Chem 78: 1093–1103.
22. Lowe JB, Freeze H (1999) Naturally occurring genetic disorders of glycosyla-
tion. In: Varki A, et al. eds. Essentials of Glycobiology. New York: Cold Spring
Harbor Laboratory Press. pp 486–487.
23. Wada Y, Tajiri M, Yoshida S (2004) Hydrophilic affinity isolation and MALDI
multiple-stage tandem mass spectrometry of glycopeptides for glycoproteomics.
Anal Chem 76: 6560–6565.
24. Tanner S, Payne SH, Dasari S, Shen Z, Wilmarth PA, et al. (2008) Accurate
annotation of peptide modifications through unrestrictive database search.
J Proteome Res 7: 170–180.
25. Tarentino AL, Plummer TH (1994) Enzymatic degradation of asparagine-linked
glycans: purification, properties, and specificity of oligosaccharide-cleaving
enzymes from Flavobacterium meningosepticum. Methods Enzymol 230: 44–57.
26. Rendic ´ D, Linder A, Paschinger K, Borth N, Wilson IBH, et al. (2006)
Modulation of neural carbohydrate epitope expression in Drosophila melanogaster
cells. J Biol Chem 281: 3343–3353.
27. Wilson IBH, Harthill JE, Mullin NP, Ashford DA, Altmann F (1998) Core a1,3-
fucose is a key part of the epitope recognized by antibodies reacting against plant
N-linked oligosaccharides and is present in a wide variety of plant extracts.
Glycobiology 8: 651–661.
28. Yano H, Goto S (2008) Spatial and temporal regulation of glycosylation during
Drosophila eye development. Cell Tissue Res DOI 10.1007/s00441-009-0753-6.
29. Fabini G, Freilinger A, Altmann F, Wilson IBH (2001) Identification of core
a1,3-fucosylated glycans and cloning of the requisite fucosyltransferase cDNA
from Drosophila melanogaster. J Biol Chem 276: 28058–28067.
30. Aoki K, Perlman M, Lim JM, Cantu R, Wells L, et al. (2007) Dynamic
developmental elaboration of N-linked glycan complexity in the Drosophila
melanogaster embryo. J Biol Chem 282: 9127–9142.
31. Altmann F, Kornfeld G, Dalik T, Staudacher E, Glossl J (1993) Processing of
asparagine-linked oligosaccharides in insect cells. N-Acetylglucosaminyltransfer-
ase I and II activities in cultured lepidopteran cells. Glycobiology 3: 619–625.
32. Staudacher E, Marz L (1998) Strict order of (Fuc to Asn-linked GlcNAc)
fucosyltransferases forming core-difucosylated structure. Glycoconjugate J 15:
355–360.
33. Paschinger K, Staudacher E, Stemmer U, Fabini G, Wilson IBH (2005)
Fucosyltransferase substrate specificity and the order of fucosylation in
invertebrates. Glycobiology 15: 463–474.
34. Choe J, Kelker MS, Wilson IA (2005) Crystal structure of human Toll-like
receptor 3 (TLR3) ectodomain. Science 309: 581–585.
35. Kolarich D, Altmann F, Sunderasan E (2006) Structural analysis of the
glycoprotein allergen Hev b 4 from natural rubber latex by mass spectrometry.
Biochim Biophys Acta 1760: 715–720.
36. Wada Y, Azadi P, Costello CE, Dell A, Dwek RA, et al. (2007) Comparison of
the methods for profiling glycoprotein glycans–HUPO human disease
glycomics/proteome initiative multi-institutional study. Glycobiology 17:
411–422.
37. Nishihara S, Ueda R, Goto S, Toyoda H, Ishida H, et al. (2004) Approach for
functional analysis of glycan using RNA interference. Glycoconjugate J 21:
63–68.
38. Hale JE, Butler JP, Knierman MD, Becker GW (2000) Increased sensitivity of
tryptic peptide detection by MALDI-TOF mass spectrometry is achieved by
conversion of lysine to homoarginine. Anal Biochem 287: 110–117.
39. Tulsiani DRP, Hubbard SC, Robbins PW, Touster O (1982) a-D-Mannosidases
of rat liver Golgi membranes. J Biol Chem 257: 3660–3668.
40. Sarkar M, Leventis PA, Silvescu CI, Reinhold VN, Shachter H, et al. (2006) Null
mutations in Drosophila N-acetylglucosaminyltransferase I produce defects in
locomotion and a reduced life span. J Biol Chem 281: 12776–12785.
41. Chui D, Oh-Eda M, Liao Y, Panneerselvam K, Lai A, et al. (1997) Alpha-
mannosidase-II deficiency results in dyserythropoiesis and unveils an alternate
pathway in oligosaccharide biosynthesis. Cell 90: 157–167.
42. Helenius A, Aebi M (2001) Intracellular functions of N-linked glycans. Science
291: 2364–2369.
43. Kleizen B, Braakman I (2004) Protein folding and quality control in the
endoplasmic reticulum. Curr Opin Cell Biol 16: 343–349.
44. Rosenbaum EE, Hardie RC, Colley NJ (2005) Calnexin is essential for
rhodopsin maturation. Ca
2+ regulation and photoreceptor cell survival. Neuron
49: 229–241.
45. Ito Y, Hagihara S, Matsuo I, Totani K (2005) Structural approaches to the study
of oligosaccharides in glycoprotein quality control. Curr Opin Struct Biol 15:
481–489.
46. Fujita SC, Zipursky SL, Benzer S, Ferrus A, Shotwell SL (1982) Monoclonal
antibodies against the Drosophila nervous system. Proc Natl Acad Sci USA 79:
7929–7933.
47. Zipursky SL, Venkatesh TR, Teplow DB, Benzer S (1984) Neuronal
development in the Drosophila retina: monoclonal antibodies as molecular
probes. Cell 36: 15–26.
48. Zipursky SL, Venkatesh TR, Benzer S (1985) From monoclonal antibody to
gene for a neuron specific glycoprotein in Drosophila. Proc Natl Acad Sci USA 82:
1855–1859.
49. Brancia FL, Oliver SG, Gaskell SJ (2000) Improved matrix-assisted laser
desorption/ionization mass spectrometric analysis of tryptic hydrolysates of
proteins following guanidination of lysine-containing peptides. Rapid Commun
Mass Spectrum 14: 2070–2073.
50. Hase S, Ikenaka T, Matsushima Y (1978) Structure analysis of oligosaccharides
by tagging of the reducing end sugars with a fluorescent compound. Biochem
Biophys Res Commun 85: 257–263.
51. Hase S, Ikenaka T (1990) Estimation of elution times on reversed-phase high-
performance liquid chromatography of pyridylamino derivatives of sugar chains
from glycoproteins. Anal Biochem 184: 135–138.
Glycoform of Chaptin
PLoS ONE | www.plosone.org 13 May 2009 | Volume 4 | Issue 5 | e5434